Description
Recombinant monoclonal antibody to Nerve Growth Factor. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma alphaD11. This is a chimeric antibody created to reduce immunogenicity during in vivo applications.
Target
Nerve Growth Factor
Target Alias Names
NGF, Ad11, alpha-D11, αD11
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression